Clinical trials: Renal AL Amyloidosis
Cancer
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
This is a phase III, randomized, double-blind, placebo-controlled, multicenter study of the clinical response to fentanyl sublingual spray as a treatment for breakthrough cancer pain.
- Trial name
- NCT00538850
- Testing
- Fentanyl sublingual spray
- Where
- United States
- Volunteers
- 130 people
- Sponsor
- INSYS Therapeutics Inc
Amyloidosis
Renal AL Amyloid Involvement and NEOD001
This is a multicenter, Phase 2b, randomized, double-blind, placebo-controlled, two-arm, parallel-group efficacy and safety study of NEOD001 as a single agent administered intravenously in adults with AL amyloidosis who have a…
- Trial name
- RAIN (NCT03168906)
- Testing
- NEOD001
- Where
- 9 sites in United States
- Volunteers
- 12 people
- Sponsor
- Tufts Medical Center